Evangelismos Hospital   Report issue

Academic/Hospital Phase 4
Founded: Evangelismos Greece (1884)

Organization Overview

First Clinical Trial
2013
NCT02122484
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Evangelismos Hospital | Evangelismos Hospital, Athens, Greece

Active Ingredients

Drugs in Phase 4 Trials (5)

citalopram (celexa) (1 trial)

colchicine (colbenemid) (1 trial)

grape seed extract (1 trial)

pea protein (1 trial)

xyloglucan (1 trial)

Drugs in Other Trials (1)

oxygen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chest Pain (Phase 4)

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Reperfusion Injury (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6